Fact sheet
Partners
ASX
LCT 0.042 Last updated EOD 21st December 2018
Fact sheet
The following fact sheets provide a summary of our current business and research pipeline.
Alternatively you might like to contact us.
Technology platforms
Our breakthrough encapsulation delivery technology, IMMUPEL™, enables treatments to be delivered without immunosuppression.


